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Maturation markeral virus (HRSV), human metapneumovirus (HMPV), and human parainﬂuenza
virus type 3 (HPIV3) are common, important respiratory pathogens, but HRSV has a substantially greater
impact with regard to acute disease, long-term effects on airway function, and frequency of re-infection. It
has been reported to strongly interfere with the functioning of dendritic cells (DC). We compared HRSV to
HMPV and HPIV3 with regard to their effects on human monocyte-derived immature DC (IDC). Side-by-side
analysis distinguished between common effects versus those speciﬁc to individual viruses. The use of GFP-
expressing viruses yielded clear identiﬁcation of robustly infected cells and provided the means to
distinguish between direct effects of robust viral gene expression versus bystander effects. All three viruses
infected inefﬁciently based on GFP expression, with considerable donor-to donor-variability. The GFP-
negative cells exhibited low, abortive levels of viral RNA synthesis. The three viruses induced low-to-
moderate levels of DC maturation and cytokine/chemokine responses, increasing slightly in the order HRSV,
HMPV, and HPIV3. Infection at the individual cell level was relatively benign, such that in general GFP-
positive cells were neither more nor less able to mature compared to GFP-negative bystanders, and cells were
responsive to a secondary treatment with lipopolysaccharide, indicating that the ability to mature was not
impaired. However, there was a single exception, namely that HPIV3 down-regulated CD38 expression at the
RNA level. Maturation by these viruses was anti-apoptotic. Inefﬁcient infection of IDC and sub-optimal
maturation might result in reduced immune responses, but these effects would be common to all three
viruses rather than speciﬁc to HRSV.
Published by Elsevier Inc.Introduction
We compared the effects of infection of human monocyte-derived
immature dendritic cells (IDC) by human respiratory syncytial virus
(HRSV) in a side-by-side comparison with human metapneumovirus
(HMPV) and human parainﬂuenza virus type 3 (HPIV3) using viruses
engineered to express enhanced green ﬂuorescent protein (GFP).
HRSV is recognized as the most important viral agent of serious
pediatric respiratory tract disease worldwide (CDC, 2007; Collins and
Crowe, 2007; Collins and Graham, 2008; Nicholson et al., 2006).
Although known primarily as a pediatric pathogen, HRSV can infect
and cause disease in individuals of all ages and can be particularlySouth Dr MSC 8007, Bethesda,
olz).
nc.serious in the elderly and in severely immunosuppressed individuals
such as allogeneic hematopoietic stem cell transplant recipients
(Falsey andWalsh, 2000). HMPVwas ﬁrst described in 2001 following
its isolation from infants and children who were experiencing HRSV-
like disease of unknown etiology (van den Hoogen et al., 2001). HMPV
has gained recognition as an important agent of the respiratory tract
diseaseworldwide, especially in the pediatric and elderly populations,
although its impact appears to be substantially less than that of HRSV
(Hamelin et al., 2004; Williams et al., 2004). HPIV serotypes 1, 2, and 3
(HPIV1, 2, and 3) as a group are second only to HRSV as a cause of
serious respiratory tract disease in infants and children (Hall, 2001;
Welliver et al., 1986). The impact of HPIV3 is greater than that of HPIV1
and HPIV2. HRSV, HMPV and the HPIVs are non-segmented negative-
strand RNA viruses of family Paramyxoviridae, which comprises two
subfamilies: HRSV and HMPV belong to subfamily Pneumovirinae and
are classiﬁed separately in genus Pneumovirus and Metapneumovirus,
170 C. Le Nouën et al. / Virology 385 (2009) 169–182respectively, and HPIV3 belongs to subfamily Paramyxovirinae and is
classiﬁed in genus Respirovirus.
Myeloid (also called conventional) DC are potent antigen present-
ing cells that activate CD4+ and CD8+ T lymphocytes and play a major
role in initiating and modulating the adaptive immune response and
also contribute to innate immunity (Grayson and Holtzman, 2007). DC
reside in peripheral tissues in an immature phenotype that is
specialized for the uptake and processing of antigen and exert a
sentinel function for incoming antigens. In infected tissue, their
numbers are augmented by the chemotactic inﬂux of IDC precursors
that appear to originate primarily from circulatingmonocytes (Auffray
et al., 2007; Geissmann, 2007; Geissmann et al., 2008). Exposure of
IDC to microbes or inﬂammatory cytokines such as tumor necrosis
factor (TNF)-α initiates a maturation process of phenotypic and
functional changes. This involves the increased surface expression of a
panel of cell surface proteins that are correlates of DC maturation and
T cell stimulatory capability, including Major Histocompatibility
Complex (MHC) class I and II molecules; T cell co-stimulatory
molecules CD80 (B7.1), CD86 (B7.2), and CD40; maturation markerFig. 1. Infectivity of rgHMPVs, rgHRSV, or rgHPIV3 for human IDC. (A) Primary data from a re
with the indicated virus or with an equivalent amount of the corresponding UV-inactivat
cytometry. The percentages of GFP-positive cells are shown. (B) Summary of data from 10 d
analyzed by ﬂow cytometry as above. Each different symbol indicates the percentage of GFP
This did not differ signiﬁcantly between the three viruses (pb0.05).CD83; the signaling receptor CD38; and CD54 (intercellular adhesion
molecule-1 [ICAM-1]) (de la Fuente et al., 2005; Frasca et al., 2006;
Lipscomb and Masten, 2002; Prechtel and Steinkasserer, 2007;
Quezada et al., 2004; Reis e Sousa, 2006; Schuurhuis et al., 2006;
Shen and Rock, 2006). Maturing DC secrete an array of chemokines,
cytokines, and interferons involved in innate immunity and T cell
activation.Maturation also changes the proﬁle of chemokine receptors
involved in directing DC migration (Lukacs-Kornek et al., 2008).
Maturing DC trafﬁc via the afferent lymphatics into the T cell area of
the draining lymph node to interact with and activate T cells. Ex vivo,
DC with a phenotype closely resembling that of IDC can be generated
by culturing peripheral blood monocytes with granulocyte/macro-
phage colony-stimulating factor (GM-CSF) and interleukin (IL)-4
(Kumar and Jack, 2006). As for any in vitro model, there are caveats.
In particular, the isolation process via CD14 positive selection may
affect the reactogenicity in response to TLR ligands (Elkord et al.,
2005). In vitro maturation conditions cannot match the inﬂammatory
environment of the lung. That said, human dendritic cells derived
from GM-CSF/IL-4 treated monocytes are currently the most widelypresentative donor. IDC were mock-treated or inoculated at an input MOI of 3 PFU/cell
ed virus. Forty hours later, the number of GFP-positive cells was determined by ﬂow
ifferent donors. Immature DC were inoculated with rgHMPVs, rgHRSV or rgHPIV3 and
-positive cells for an individual donor, and the median value for each virus is indicated.
Fig. 2. Cell surface expression of maturation markers on DC following inoculation with rgHMPVs, rgHRSV, or rgHPIV3. IDC from individual donors [n=10, except for CD40 (n=8) and
HLA-ABC (n=7)] were mock inoculated, inoculated with an input MOI of 3 PFU/cell with the indicated live or UV-inactivated virus, or treated with 1 μg/ml of LPS. Forty hours after
inoculation, the cells were harvested and analyzed by ﬂow cytometry for cell surface expression of the indicated maturation markers. The box plots show the median (horizontal
line), ﬂanked by the 2nd and 3rd quartile. The outer bars show the range of values. Treatments sharing the same lower case letters do not differ signiﬁcantly at the pb0.05 conﬁdence
level for the global experiment (Materials and methods).
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Table 1
Viral RNA in GFP-positive and GFP-negative DC 24 h after inoculation with rgHMPVs,
rgHRSV, or rgHPIV3a
GFP-negativeb GFP-positiveb GFP-positive vs.
GFP-negativec
rgHMPVs 124 24,558b 198
rgHRSV 182 3,801 21
rgHPIV3 2,600 291,251 112
a Monocyte-derived IDC were inoculated with rgHMPVs, or rgHRSV, or rgHPIV3 at an
input MOI of 3 PFU/cell or with an equivalent amount of UV-inactivated virus, and 24 h
later the cells were sorted for GFP expression. The purity of the GFP-negative cell
populations was 92–99% live GFP-negative cells, with all of the remaining cells
corresponding todeadGFP-negative cells. Post-sort analysis indicated that themaximum
level of contaminating GFP-positive cells in the GFP-negative populationwas below 0.1%.
The purity of the GFP-positive populations was 88–91% live GFP-positive cells, with the
remaining cells corresponding to live or dead GFP-negative cells and some dead GFP-
positive cells. Total cell-associated RNAwas prepared, and qRT-PCRwas performed using
primers speciﬁc for the virus-expressed GFP sequences (see Materials and methods).
Human β-actin was used as housekeeping gene for internal normalization.
b Fold increase versus DC inoculated with the corresponding UV-inactivated control.
c Fold difference between GFP-positive versus GFP-negative cells.
172 C. Le Nouën et al. / Virology 385 (2009) 169–182used model for detailed study of the effects of human pathogens on
DC.
HRSV, HMPV, and HPIV3 are generally similar with regard to their
tissue tropism in vivo and spectrum of disease. Yet, the impact of HRSV
on human health is much greater both with regard to disease burden
and long-term effects on airway function and reactivity (Collins and
Crowe, 2007; Collins and Graham, 2008; Glezen, 1990; Lee et al.,
2005). Also, while all three viruses have the capability to re-infect
throughout life without signiﬁcant antigenic change, re-infection by
HRSV is more frequent and imposes a much greater burden of
morbidity and mortality. It is commonly suspected that these
attributes of HRSV may reﬂect an ability of the virus to manipulate
and blunt the host immune response and to impart long-term
deleterious effects, although the speciﬁc mechanisms involved remain
poorly understood (Collins and Graham, 2008). The central role of DC
in initiating and shaping the immune response, together with their
presence at and recruitment to the site of infection and concomitant
exposure to infectious virus, makes them obvious candidates for viral
manipulation of the host immune response.
A number of studies have investigated the effects of interaction of
IDC (either isolated directly from blood or monocyte-derived) with
HRSV and, in two cases each, HMPV or HPIV3 (Bartz et al., 2002, 2003;
Chi et al., 2006; de Graaff et al., 2005; Guerrero-Plata et al., 2005;
Horga et al., 2005; Jones et al., 2006; Plotnicky-Gilquin et al., 2001; Tan
et al., 2007), but relatively few experiments had compared any of
these viruses in parallel (Bartz et al., 2002; de Graaff et al., 2005;
Guerrero-Plata et al., 2006; Jones et al., 2006). Previous studies have
tended to highlight effects that were suggested to be speciﬁc
characteristics of an individual virus, including immunosuppressive
effects of HRSV observed in some studies (Bartz et al., 2003; Guerrero-
Plata et al., 2006) that were not observed by others (Jones et al., 2006),
differential effects on cytokine/chemokine expression by HRSV versus
HMPV (Guerrero-Plata et al., 2006), impaired stimulation of DC
maturation by HMPV (Tan et al., 2007), and virus-induced apoptosis
by HPIV3 (Horga et al., 2005; Plotnicky-Gilquin et al., 2001). In the
present study, we addressed this uncertainty by a side-by-side
comparison of puriﬁed HRSV, HMPV and HPIV3, each expressing
GFP. A side-by-side comparison provides for clear identiﬁcation of
effects that are speciﬁc for a particular virus versus effects common to
all three, and the use of GFP-expressing viruses made it possible to
distinguish between effects in GFP-positive and GFP-negative cells. In
general, we did not observe dramatic effects speciﬁc to particular
viruses. All three viruses infected IDCs inefﬁciently and induced low-
to-moderate maturation and cytokine/chemokine expression. Infec-
tion was relatively benign, such that, for the most part, GFP-positive
cells were neither more nor less able to mature compared to GFP-
negative bystanders. Maturation induced by each of the three viruses
was anti-apoptotic. In general, we observed sub-optimal maturation,
rather than strong virus-speciﬁc impairment. These three common
respiratory viruses may have evolved similarly to minimize their
immunologic footprint.
Results
rgHMPVs, rgHRSV and rgHPIV3 have similar, low efﬁciencies of infection
for human IDC
Human monocyte-derived IDC were infected at an input MOI of
3 PFU/cell with puriﬁed recombinant GFP-expressing HMPV, HRSV,
or HPIV3 (rgHMPVs, rgHRSV, or rgHPIV3). The rgHMPVs virus was a
version containing an SH gene that had been modiﬁed to silently
remove tracts of A or T residues that were sites of spontaneous
mutations during passage in vitro (Biacchesi et al., 2007). GFP
expression was detectable by 12 to 15 h post-infection, comparable to
the kinetics of expression in epithelial-type cell lines (not shown).
Forty hours after infection, GFP expression was assessed by ﬂowcytometry. Fig. 1A shows dot plots of an experiment with cells from a
single donor, and Fig. 1B summarizes data from a total of 10 donors.
As expected, no GFP-positive cells were detected in DC inoculated
with UV-inactivated virus. The percentage of GFP-positive cells
among the three viruses ranged from 2.2% to 9.3% for rgHMPVs
(median of 3.4%), from 2.7% to 6.4% for rgHRSV (median of 4.9%), and
from 0.4% to 17.6% for rgHPIV3 (median of 4.0%). DC from certain
donors exhibited apparent differences in permissiveness to the three
human viruses. For example, cells from one donor (indicated with
asterisks in Fig. 1B) were nearly 3-fold more permissive for rgHPIV3
compared to rgHRSV. Conversely, cells from a second donor
(indicated with ﬁlled circles in Fig. 1B) were 16-fold less permissive
for HPIV3 than for HRSV. The possible donor-to-donor variability in
permissiveness will need further studies for substantiation. Overall,
the median percentage of GFP-positive cells (n=10 donors) was not
signiﬁcantly different among the three respiratory viruses (PN0.05),
indicating a general similarity in permissiveness of IDC for infection
by the three different viruses. In contrast, infection with recombinant
Newcastle disease virus expressing GFP (generously provided by Dr.
Siba K. Samal, University of Maryland) at the same input MOI
resulted in approximately 80% GFP-positive DC (not shown),
indicating the low infectivity was speciﬁc to these human viruses
rather than our experimental conditions. In addition, infection of the
human airway epithelium A549 cell line with these three human
viruses at the same input MOI resulted in approximately 60–85%
GFP-positive cells (not shown), indicating that there was at least a
15-fold difference in permissiveness between human IDC and A549
cells.
The ability of the three viruses to induce up-regulation of surface
markers increased in the order: rgHRSV, rgHMPVs, rgHPIV3
IDC were mock-treated, inoculated with LPS (1 μg/ml) as a positive
control, or inoculated with rgHRSV, rgHMPVs, or rgHPIV3 (each at an
input MOI of 3 PFU/cell), or with UV-inactivated counterparts. Forty
hours later, cells were analyzed by ﬂow cytometry for cell surface
expression of seven maturation markers: CD38, CD54, CD80, CD86,
CD40, CD83, and HLA-ABC. Brieﬂy, CD38 is a receptor and ectoenzyme
involved in chemotaxis, transendothelial migration, inhibition of
apoptosis, and Th1 polarization (Frasca et al., 2006); CD54 (ICAM-1)
plays a key role in contact with T lymphocytes and enhances the
density of MHCII and CD86 at the contact area (de la Fuente et al.,
2005); CD80 and CD86 are co-stimulatory molecules that interact
with CD28 on naïve T cells (Lipscomb and Masten, 2002); CD83 is
involved in T cell activation (Prechtel et al., 2007); CD40 is a co-
stimulatory molecule that interacts with CD40 ligand (CD154) on T
}Fig. 3. Cell surface expression of maturation markers on GFP-positive versus GFP-negative DC following inoculation with rgHMPVs, rgHRSV and rgHPIV3. IDC were mock inoculated
or infected at an input MOI of 3 PFU/cell with the indicated virus. Forty hours after inoculation, GFP-positive and GFP-negative cells were analyzed by ﬂow cytometry for cell surface
expression of the indicated maturation markers. nN10 different donors, except for CD40 (n=8) and HLA-ABC (n=7). (+), GFP-positive population, (−), GFP-negative population. The
box plots show the median (horizontal line), ﬂanked by the 2nd and 3rd quartile. The outer bars show the range of values. Signiﬁcant differences at the pb0.05 conﬁdence level for
the global experiment between the GFP-positive and -negative populations are marked by asterisks.
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MHC class I genes, A, B, and C, detected by an antibody to a common
epitope. Fig. S1 shows primary data from a representative donor for
six of these markers, and Fig. 2 summarizes data for all markers and
donors. As would be expected, mock-infected DC exhibited a low level
of cell surface expression of the maturation markers (Figs. S1 and 2),
with some donor-to-donor variability. Compared to mock-infected
cells, the positive control LPS induced a strong, signiﬁcant increase in
surface expression of each of the seven markers. In general, the DC
response to LPS tended to be greater than the responses to the three
viruses, although this was statistically signiﬁcant only versus rgHRSV
for CD38, CD80, and CD40, versus rgHMPVs for CD80 and CD40, and
versus rgHPIV3 for CD80. Among the viruses, the response to rgHPIV3
was greater than to rgHRSV for CD38, CD80, and CD40, and versus
rgHMPVs for CD80. For all of the markers, the response to each UV-
inactivated virus was very similar to that for mock-treatment.
Expression was greater with live virus than its corresponding UV-
inactivated control (although the increase was not always statistically
signiﬁcant) except in the case of CD83 and CD40 for rgHRSV and
rgHMPVs and in the case of HLA-ABC. This indicated that intracellular
viral RNA replication, which is the viral activity that is most sensitive
to UV irradiation, was necessary to induce maturation. Taken together,
these data indicate that the three viruses were broadly similar in their
effect on up-regulation of DC maturation markers, but the magnitude
of up-regulation increased in the order: rgHRSV, rgHMPVs, rgHPIV3.
Viral RNA synthesis in GFP-negative versus GFP-positive DC
GFP expression in DC, as well as in highly permissive epithelial-
type cell lines, was evident only beginning at 12–15 h post-infection,
and thus is a marker for robust viral RNA replication and gene
expression. Therefore, it was unclear whether the GFP-negative
population of virus-inoculated DC was completely resistant to
infection or supported a low-level infection. To investigate this,
aliquots of IDC prepared from a single donor were inoculated with
each of the three viruses as well as with UV-inactivated controls.
Twenty-four hours post-inoculation, the cells were sorted on the basis
of GFP expression and quantitative RT-PCR was used to measure the
amount of cell-associated GFP RNA in the GFP-negative versus theFig. 4. Reduced expression of CD38 on GFP-positive DC inoculated with rgHPIV3 is not a
inoculated (lanes 1 and 2), or inoculatedwith 1 μg/ml of LPS (lanes 3 and 4), or inoculated wit
cell. Twenty-four hours later, one culture of each pair was stimulated (or restimulated if the cu
other was not stimulated (odd numbered lanes). Twenty-four hours later, the paired cultures
In the case of each pair of virus-inoculated cultures, the GFP-positive and GFP-negative fracti
The differences are not statistically signiﬁcant.GFP-positive population. The cells that had been inoculated with UV-
inactivated virus (and had been passed through the cell sorter in
parallel) served as a control for the background of preformed RNA
resulting from phagocytosis or cell-surface binding of the input viral
inoculum. Quantitative RT-PCR was performed on RNA from each set
of GFP-positive and GFP-negative cells and the results were normal-
ized against the respective UV-inactivated control (Table 1). As
expected, in the GFP-positive population of DC inoculated with
rgHRSV, rgHMPVs, or rgHPIV3, the level of GFP RNA was strongly
increased compared to the UV-inactivated controls, reﬂecting robust
viral RNA synthesis. However, in GFP-negative population, the GFP
RNA levels also were substantially increased: compared to the
corresponding UV-inactivated controls, the level of GFP RNA in the
sorted GFP-negative cells was increased 124-fold for rgHMPVs, 182-
fold for rgHRSV, and 2600-fold for rgHPIV3. This strongly suggests
that infection and viral RNA synthesis occurred in at least some of the
GFP-negative cells for each of the three viruses. However, the amount
of GFP RNAwas 21- to 198-fold lower in the GFP-negative cells than in
GFP-positive cells of the same samples. This suggests that infection in
the GFP-negative cells was highly restricted and/or abortive.
Maturation of GFP-positive versus GFP-negative DC: CD38 expression
alone is down-regulated by rgHPIV3
We next investigated possible direct effects of robust viral gene
expression and genome replication on maturation. This was done by
analyzing the level of expression of the maturation markers in the
GFP-positive versus the GFP-negative populations of IDC inoculated
with each of the three viruses (Fig. 3). Remarkably, in most cases there
was little difference in the cell surface expression of the above-
mentioned seven maturation markers in GFP-positive versus GFP-
negative cells. This suggested that, at the individual cell level, robust
viral genome replication and gene expression were not required to
drive maturation and, conversely, did not impair the ability of IDC to
mature. There was a single instance in which there was signiﬁcantly
greater expression of a maturation marker in the GFP-positive versus
GFP-negative population, namely CD86 for rgHMPVs. In several other
instances, expression also appeared to be greater in the GFP-positive
versus GFP-negative population, but the differences were notugmented by subsequent stimulation with LPS. Duplicate cultures of IDC were mock
h rgHPIV3 (lanes 5–8), rHMPVs (lanes 9–12), or rgHRSV (lanes 13–16) at anMOI of 3 PFU/
lture had previously received LPS) with 1 μg/ml of LPS (even numbered lanes), while the
were harvested and analyzed by ﬂow cytometry for the cell surface expression of CD38.
ons were analyzed separately. The different symbols indicate the three different donors.
Fig. 5. Cytokine production by DC. IDC were mock inoculated, or stimulated with 1 μg/ml of LPS, or inoculated with an MOI of 3 PFU/cell with rgHMPVs, rgHRSV, rgHPIV3, or with a
corresponding amount of UV-inactivated virus. At 3, 14, 22 and 40 h.p.i., medium supernatants were collected from duplicate wells for each treatment and subsequently tested for
cytokine quantity using a multiplex bead assay or, for IFNα, IFNβ and CXCL10, by ELISA. n=3 different donors for the 3, 14 and 22 h time points and 3 additional donors (total of 6) for
the 40 h time point. For each given cytokine, and only for the 40 h time point, treatments sharing the same lowercase letters do not differ signiﬁcantly at the pb0.05 conﬁdence level
for the global experiment (Materials and methods). LPS was not included in the statistical analysis in cases where it induced a much stronger response than the viruses, namely with
CCL2, CCL3, CCL4, CCL5 and TNFα. This is part of the experiment shown in Table 2.
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Table 2
Peak concentrations of cytokines produced by DC inoculated with rgHMPVs, rgHRSV, or rgHPIV3a
Cytokine Mockb rgHMPVsb rgHRSVb rgHPIV3b LPSb
Interferons IFNα 0 81 0 492 0
IFNβ 0 14 0 67 85
Chemokines CCL2 (MCP1) 44 2,681 (6) 1,951 (4) 2,681 (6) 3,703 (8)
CCL3 (MIP1α) 65 113 (2) 75 (1) 412 (6) N10,000 (N154)
CCL4 (MIP1β) 274 948 (3) 320 (1) 1,921 (7) N10,000 (N36)
CCL5 (Rantes) 0 147 131 738 N10,000
CXCL8 (IL-8) 138 133 (1) 131 (1) 352 (3) 6,270 (45)
CXCL10 (IP10) 23 17,395 (756) 9,230 (401) 16,733 (728) 4,921 (214)
Interleukins IL-1ra 1,156 4,590 (4) 3,945 (3) 3,307 (3) 4,233 (4)
IL-1α 6 208 (35) 209 (35) 212 (35) 356 (59)
IL-6 29 343 (12) 163 (6) 646 (22) N10,000 (N345)
TNF family TNFα 7 48 (7) 16 (2) 175 (25) 5,842 (835)
a Monocyte-derived IDCwere inoculatedwith 3 PFU/cell of the indicated virus or with 1 μg/ml LPS. Duplicate samples from six donors were taken at various times post-inoculation
(see the legend to Fig. 5) and cytokine concentrationswere assayed bya luminexbead assay (or by ELISA for IFNα, IFNβ and CXCL10) (parts of this experiment also are depicted in Fig. 5).
Shown here are maximummedian values irrespective of time. All of the cytokines from the assay set that were increased in at least one of the virus-infected cells compared to mock-
inoculated cells are shown. Cytokines that were induced by LPS only (not shown) were: CX3CL1 (fractalkine), IL-7, IL-10, IL-12p70, IL-15, IFNγ, G-GSF, GM-CSF, TGFα, and VEGF.
Cytokines that were not signiﬁcantly induced by any inoculation were: CCL11 (Eotaxin), IL-1β, IL-2, IL-4, IL-5, IL-13, IL-17, and EGF.
b Cytokine concentration in clariﬁed supernatants, expressed as pg/ml (or IU/ml for IFNβ) and, in parentheses, as fold-difference compared tomock-inoculated DC, unless the value
for mock was “0”.
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for rgHMPVs).
There also was a single instance in which there was signiﬁcantly
reduced expression of a maturation marker in the GFP-positive versus
GFP-negative population, namely CD38 for rgHPIV3 (Fig. 3; represen-
tative results with cells from a single donor are shown in Fig. S2).
These data suggest that the more robust level of rgHPIV3 infection in
the GFP-positive cells interfered with the maturation-driven up-
regulation in the surface expression of CD38.
We askedwhether viral infection in the rgHPIV3-GFP-positive cells
actively impaired expression of CD38 associated with DC maturation,
or whether rgHPIV3 simply was an inadequate stimulus. Duplicate
wells of IDC from three different donors were inoculatedwith rgHPIV3
and incubated for 24 h, at which time LPS (1 μg/ml) was added to one
of the two wells. In mock-treated control cells, stimulation with LPS
for the last 24 of the 48 h culture period increased cell surface
expression of CD38, as expected (Fig. 4, lane 2). Since CD38 expression
was equally high in the DC treated with LPS for 48 h versus 24 h (Fig. 4,
lane 3 versus lane 2), we concluded that stimulation with LPS for 24 h
provided maximal stimulation for comparison to the respiratory
viruses. Of the cells inoculated with rgHPIV3, the GFP-negative
fraction strongly expressed CD38, and this level was increased only
minimally by stimulation with LPS at 24 h (Fig. 4, lane 8 versus 7).
Notably, the poor expression of CD38 in the GFP-positive fraction of
rgHPIV3-inoculated cells was only marginally increased by LPS (Fig. 4,
lane 6 versus 5). Finally, in contrast to rgHPIV3, LPS strongly increased
the low level of CD38 expression in DC that had been inoculated with
rgHMPVs (Fig. 4, lanes 12 versus 11) and rgHRSV (lanes 16 versus 15).
Therefore, while the low CD38 expression in rgHMPVs- and rgHRSV-
treated cells was due to insufﬁcient stimulation, the low expression of
CD38 in the rgHPIV3/GFP-positive cells was uniquely due to active
impairment of CD38 expression by rgHPIV3.
We then asked whether the impaired expression of CD38 in the
rgHPIV3-inoculated GFP-positive cells was at the level of intracellular
mRNA abundance. Cells from two donors were inoculated with
rgHPIV3 at an MOI of 10 PFU/cell. This resulted in 7% and 11% GFP-
positive cells for donor 1 and 2, respectively, at 24 h. After 24 h, cells
were sorted into GFP-positive and GFP-negative fractions. The purity
of the GFP-positive population was 93% (donor 1) and 81% (donor 2).
The remaining 7% and 19% of cells were live or dead GFP-negative
cells, and a few dead GFP-positive cells. The purity of the GFP-negative
populationwas 97% (donor 1) and 89% (donor 2); the 3% and 11% of the
remaining cells were identiﬁed as dead GFP-negative cells. RT-qPCR of
the sorted fractions showed that the level of intracellular CD38 mRNA
in the GFP-positive cells was 4 and 5-fold lower (donor 1 and 2,respectively) than that in GFP-negative cells, which could account for
the magnitude of the difference in cell surface expression. Therefore,
expression of CD38 is inhibited at the level of intracellular mRNA
abundance.
rgHPIV3, rgHMPVs and rgHRSV induce a similar array of cytokines
IDC were mock inoculated, or stimulated with 1 μg/ml of LPS, or
inoculated at an MOI of 3 PFU/cell with rgHMPVs, rgHRSV, rgHPIV3 or
with their UV-inactivated counterparts. At 3, 12, 24 and 40 h.p.i.,
supernatants were harvested and assayed for the presence of 30
cytokines and factors (see Materials and methods for the complete
list): the time course of production of selected cytokines is shown in
Fig. 5, and the peak concentrations of all of the virus-induced
cytokines are shown in Table 2. Out of 30 cytokines tested, 24 were
detected following stimulation with LPS, whereas only 12 were
detected following virus infection (Table 2). The virus-induced species
included type I interferons (IFN), C-C chemokines (four out of ﬁve
tested), C-X-C chemokines (two out of three tested), interleukins
(three out of 13 tested), and TNFα. Growth factors (TGFα, G-CSF, GM-
CSF, VEGF, EGF) were not detected. These increases were not observed
for DC infected with UV-inactivated viruses (data not shown),
indicating that viral genome replication was required.
The production of IFNβ by DC after virus infection was delayed
as compared to the rapid production following LPS stimulation (Fig.
5). Essentially no IFNβ was induced by rgHRSV, whereas rgHPIV3
was a more efﬁcient inducer than rgHMPVs (Table 2). The proﬁle of
IFNα production was similar to that of IFNβ, such that little or
none was produced in response to rgHRSV, whereas rgHPIV3 was
the most efﬁcient inducer. Among the interleukins, treatment with
LPS, rgHMPVs, rgHRSV, or rgHPIV3 up-regulated expression of the
pro-inﬂammatory cytokines IL-1α and IL-6 as well as the IL-1
receptor antagonist (IL-1ra, also called the IL-1 inhibitor) (Table 2).
IL-1ra is noteworthy because it competes with IL-1α/β for binding
to the IL-1 receptor and down-regulates IL-1-mediated effects, and
thus is a natural anti-inﬂammatory factor. It was suggested
previously that production of this antagonist by HRSV might result
in reduced T cell activation, as a possible mechanism of reduced
immunogenicity (Salkind et al., 1991). Since all three viruses in the
present study induced a high level of expression of IL-1ra, any
immunosuppressive effect would not be unique to HRSV, although
it remains possible that this antagonist plays a similar role for all
three viruses in reducing immunogenicity. All three viruses also
induced detectable levels of TNFα, although induction by rgHRSV
was very weak.
Fig. 6. Apoptosis in DC inoculated with rgHMPVs, rgHRSV, or rgHPIV3: representative data from a single donor. IDC were inoculated individually with the indicated virus at an MOI of
3 PFU/cell, or mock inoculated, or inoculated with 1 μg/ml of LPS. Forty hours later, the cells were harvested and analyzed by ﬂow cytometry to identify apoptotic cells by two
parameters: side scatter, which characterizes intracellular granularity, and immunostaining with an antibody for activated caspase 3. Additional cells were treated for 4 h with 5 μM
staurosporine as a positive control for apoptosis and analyzed in parallel. The top six panels show dot plots of the total cell population for each indicated treatment/inoculation, and
the bottom six panels show GFP-negative and GFP-positive fractions of the virus-inoculated populations. Cells deﬁned as apoptotic by the two parameters are outlined in red and the
percentage is indicated. These data correspond to donor B at the bottom of Table 3.
177C. Le Nouën et al. / Virology 385 (2009) 169–182Of the panel of chemokines tested, rgHPIV3 up-regulated produc-
tion of four C-C chemokines, namely CCL2 (MCP1), CCL3 (MIP1α),
CCL4 (MIP1β), and CCL5 (RANTES) which are chemotactic for
monocytes, as well as of two C-X-C chemokines CXCL8 (IL-8, which
strongly attracts neutrophils and would augment innate immunity
(Piqueras et al., 2006)) and CXCL10 (IP10) (Fig. 5, Table 2). The
response to rgHMPVs and rgHRSV was somewhat more circum-
scribed: rgHMPVs and rgHRSV did not induce increased production of
CXCL8; in addition rgHRSV did not up-regulate CCL3 and CCL4.
However, rgHMPVs and rgHRSV, like rgHPIV3, induced strong
responses of CCL2 and CXCL10. Even though CXCL10 is regulated by
type I and type II IFN, it was strongly up-regulated by all three viruses
despite the lack of detectable IFNγ for any of the viruses and the lackof detectable type I IFN for HRSV. Thus, among the three viruses, the
induction of IFN and pro-inﬂammatory cytokines was strongest for
rgHPIV3 and weakest for rgHRSV, and the three viruses were
comparable in the production of anti-inﬂammatory IL-1ra.
The viruses block apoptosis
We evaluated the extent of apoptosis 40 h following inoculation of
IDC with each of the three viruses, a time span that in vivo would
approximately encompass the time from antigen contact to matura-
tion, migration, and activation of T cells in lymph nodes (Grayson and
Holtzman, 2007; Piqueras et al., 2006). The extent of apoptosis was
evaluated by two ﬂow cytometry-based assays. In one assay, labeled
Table 3
Apoptosis markers in DC inoculated with rgHMPVs, rgHRSV, or rgHPIV3a
Marker Donor Mock Staurosporine LPS rgHMPVs rgHRSV rgHPIV3
Total GFP+ GFP− Total GFP+ GFP− Total GFP+ GFP−
Annexin 5 Donor A 12.9 37.4 2.3 3.0 14.0 2.8 2.6 9.5 2.5 2.7 6.7 2.7
Donor B 48.6 74.5 11.4 1.7 5.5 1.7 1.5 3.5 1.5 1.5 7.1 1.4
Donor C 19.0 n.d.b 1.5 1.2 3.3 1.1 1.6 4.1 1.6 2.9 5.5 2.7
Activated caspase 3 Donor A 16.3 66.3 5.6 0.5 27.7 0.4 1.2 16.5 1.1 4.6 7.8 4.4
Donor B 52.6 89.5 0.4 0.2 7.2 0.2 0.7 5.6 0.7 0.6 16.9 0.5
a Monocyte-derived IDC from three donors (A, B, and C) were mock-treated, or treated with 1 μg/ml LPS, or treated with 5 μM of the apoptosis inducer staurosporine, or inoculated
with the indicated virus at an input MOI of 3 PFU/cell. Forty hours later (or, in the case of staurosporine, 4 h later), the cells were stained with annexin V or with antibody speciﬁc for
the activated form of caspase 3 and analyzed by ﬂow cytometry. The percentage of cells positive for the indicated apoptosis marker is shown: for the virus-inoculated cultures, values
are shown for the percentage apoptotic cells in the total culture as well as the percentage of GFP-positive and -negative cells that were apoptotic.
b nd, not done.
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dylserine, which is translocated from the inner to the outer surface of
the plasma membrane early in apoptosis. In the second assay,
apoptotic cells were identiﬁed by two parameters: (i) side scatter,
which measures intracellular granularity, which is reduced in
apoptotic cells, and (ii) immunostaining with an antibody speciﬁc
for activated caspase 3, which is one of themajor executioner caspases
and is generated from an inactive precursor by proteolysis.
Representative data for a single donor using the side scatter/
caspase 3 assay are shown in Fig. 6. In this example, 52.6% of themock-
inoculated cells were apoptotic at the 40 h time point (Fig. 6, top row).
With the apoptosis inducer staurosporine, the percentage of apoptotic
cells increased to 89.5%. Remarkably, treatment with LPS reduced the
level of apoptotic cells to 0.4%, which presumably reﬂects an anti-
apoptotic effect of DC maturation as suggested previously (Arimilli et
al., 2006; Lundqvist et al., 2002). The level of apoptotic cells with the
three viruses (Fig. 6, second row) also was low: rgHMPVs, 0.2%;
rgHRSV, 0.7%, and rgHPIV3, 0.6%. Analysis of cells that were gated on
the basis of GFP expression (Fig. 6, bottom two rows) showed the GFP-
positive fractions had the following percentages of apoptotic cells: 7.2,
5.6, and 16.9 for rgHMPVs, rgHRSV, and rgHPIV3, respectively. These
values were higher than the respective values from the GFP-
negative fractions: 0.2, 0.7, and 0.5, but nonetheless were low
compared to the mock-inoculated control. Similar results were
obtained with this assay using cells from an additional donor (Table
3, donor A) and for these two donors (donors A and B) plus a third
donor (donor C) using the annexin-V assay (Table 3). This indicated
that the three viruses were similar in the property of sparing DC
from apoptosis, presumably through the anti-apoptotic effects of
DC maturation, although this protective effect was partly negated
in the small fraction of cells that was GFP-positive and thus
robustly infected.
Discussion
We made a side-by-side comparison of the ability of GFP-
expressing HMPV, HRSV, and HPIV3 to infect and induce maturation
in human monocyte-derived IDC. Comparison of the three viruses did
not conﬁrm dramatic differences observed in some previous studies
(see Introduction and below). We found that all three viruses infected
IDC poorly, with only a few percent of cells being GFP-positive and the
remainder having low, abortive levels of viral RNA synthesis. The three
viruses induced low-to-moderate maturation of DC and moderate
cytokine/chemokine responses, with responses to HPIV3 being
somewhat greater. Infection at the individual cell level tended to be
relatively benign, such that GFP-positive cells were neither more nor
less able to mature compared to GFP-negative bystanders. The only
exceptions were that robust (GFP+) HMPV infection modestly
increased expression of CD86, and robust (GFP+) HPIV3 infection
strongly down-regulated CD38 expression at the RNA level. Finally, in
each case, maturation was anti-apoptotic.Each of the three viruses was able to infect monocyte-derived IDC
sufﬁciently to mediate strong expression of GFP in approximately 4%
of the cells. This low level of infectivity contrasts, for example, with
inﬂuenza A virus, Sendai virus, and simian virus type 5, which have
been reported to infect nearly 100% of human monocyte-derived DC
(Arimilli et al., 2006; Osterlund et al., 2005). Infection by Newcastle
disease virus also was efﬁcient in our own laboratory (not shown),
whereas infection by measles virus appeared to be intermediate in
efﬁciency (Servet-Delprat et al., 2000). The permissiveness of IDC to
infection by HPIV3 had not been reported previously. With HRSV and
HMPV, previous studies reported similar rates of infection as well as
instances of higher rates occurring at higher MOIs in a dose-
dependent fashion. Since the particle to PFU ratio of preparations of
HRSV has been reported to be very high, 3000–30,000:1 (Buynak et
al., 1978), we avoided using higher doses. The use of GFP expression
as a marker of robust viral infection likely was more reliable and
discriminating than the use of immunoﬂuorescence detection of viral
antigen, since the latter method does not distinguish between
antigen in the inoculum taken up by these actively phagocytic cells
versus that synthesized de novo. The three viruses in the present
study were at least 15-fold less efﬁcient in infecting human
monocyte-derived IDCs compared to A549 epithelium-derived cells
(data not shown).
The low efﬁciency of infection of IDC with these viruses may have
consequences for the adaptive immune response. The classical
pathway by which DCs activate CD8+ T cells involves degradation of
de novo-synthesized, intracellular antigen and presentation of the
resulting oligopeptides on MHC class I molecules. Inefﬁcient infection
and concomitant inefﬁcient antigen expression would reduce the
efﬁciency of this pathway. As an alternative pathway, IDC also can take
up exogenous antigen and degrade and display this antigen on MHC
class I molecules, a process called cross-presentation (Shen and Rock,
2006). The inefﬁcient infection observed in the present study with
HRSV, HMPV, and HPIV3 suggests that activation of CD8+ T cells
against these viruses may be more dependent on cross-presentation
and thus may be less robust than if both pathways were efﬁcient. It
also might be delayed in time, since cross-presentation would largely
depend on the initial infection of epithelial cells. As another factor, in
the absence of efﬁcient viral infection, DC maturation might be
dependent on exogenous stimuli. Indeed, we recently showed that the
maturation of human IDC in response to HRSV infection is dependent
in a large part on secreted type I IFN and is partially suppressed by the
IFN antagonists encoded by the virus (Munir et al., 2008).
We also analyzed infectivity by qRT-PCR of viral RNA present in
GFP-negative and GFP-positive cells. This showed that the GFP-
negative fraction of each population of virus-inoculated DC contained
a substantial increase in virus-speciﬁc RNA compared to controls
inoculated with UV-irradiated virus. The primary effect of UV
irradiation is to block viral genome replication (Ball and White,
1976), and thus the higher level of viral RNA in the GFP-negative
fractions compared to the cells inoculated with the UV-treated
179C. Le Nouën et al. / Virology 385 (2009) 169–182controls indicated that viral genome replication occurred in the GFP-
negative population for all three viruses. However, the amount of viral
RNA in the GFP-negative fraction was 21- to 198-fold lower than for
the GFP-positive fraction. These results suggest that infection occurred
in the GFP-negative cells, but aborted at a step following attachment,
entry, primary transcription, and one ormore initial rounds of genome
replication. However, it is unknown what percentage of GFP-negative
cells were abortively infected.
For all three viruses, maturation was ablated by UV-inactivation
of the virus and thus was dependent on intracellular genome
replication. This sensitivity to UV-inactivation had previously been
noted for HRSV and HMPV (de Graaff et al., 2005; Guerrero-Plata et
al., 2006). However, the present results differ from previous studies
with HPIV3 in which UV-inactivated virus was shown to induce an
increase of CD54 and MHCII (Plotnicky-Gilquin et al., 2001), and
CD86 and CD83 (Horga et al., 2005; Plotnicky-Gilquin et al., 2001).
Whether this reﬂects a difference in strain or methodology, such as
the use of unpuriﬁed virus in previous studies, is unknown. The
dependence on infectivity indicates that contact and uptake of the
viral inoculum by IDC was insufﬁcient to induce maturation. This
was the case even though, as noted above, preparations of these
viruses typically contain very much more viral material than is
suggested by the number of PFU and typically contain RNA of both
polarities. Thus, detection of endocytosed viral RNA by toll-like
receptor 3 (TLR3) or, in the case of HRSV, the ligation of virion-
associated F protein with TLR4 (Kurt-Jones et al., 2000), apparently
was insufﬁcient to induce maturation under these conditions. The
dependence on RNA replication suggests that maturation was
dependent on signaling in infected cells mediated by cytoplasmic
pattern recognition receptors such as RIG-I, which recognizes 5′-
triphosphorylated RNAs produced during RNA replication (Hornung
et al., 2006; Pichlmair et al., 2006).
All three viruses induced a signiﬁcant up-regulation of CD38 and
CD80. Additionally, rgHPIV3 induced signiﬁcant increases of CD83,
CD86, CD40, and CD54, while the increases associated with rgHRSV
and rgHMPVs were not statistically signiﬁcant. Previous studies had
reported varying extents of maturation (Bartz et al., 2002, 2003; de
Graaff et al., 2005; Guerrero-Plata et al., 2006; Horga et al., 2005;
Jones et al., 2006; Plotnicky-Gilquin et al., 2001), with some studies
in particular describing incomplete maturation in response to HRSV
(Bartz et al., 2002, 2003) and HMPV (Tan et al., 2007). To further
investigate whether robust infection promoted or impaired the
expression of the surface maturation markers, we evaluated the
extent of maturation of GFP-positive versus GFP-negative cells. For
rgHRSV and rgHMPVs, the extent of expression in GFP-positive cells
was similar to (e.g. CD38, CD83, CD80, CD54) or greater than (e.g.
CD86 and CD40) that of GFP-negative cells. This suggested that
robust viral genome replication and gene expression was not
inhibitory and, in the latter instances, was somewhat stimulatory.
The results were similar for rgHPIV3 except that the expression of
CD38 was signiﬁcantly reduced in GFP-positive versus GFP-negative
cells. Thus, robust rgHPIV3 genome replication and gene expression
was inhibitory to CD38 expression. Quantitative RT-PCR provided
evidence that this occurred at the level of the accumulation of CD38
mRNA. The low level of CD38 expression in rgHPIV3-inoculated cells
was not boosted by secondary stimulation with LPS, consistent with
inhibition of expression. In contrast, the low levels of CD38
expression in rgHPMVs- and rgHRSV-inoculated cells was boosted
by LPS challenge. This also was noted for several other maturation
markers (not shown), suggesting that the low-to-moderate levels of
expression of maturation markers reﬂected insufﬁcient stimulation
rather than direct impairment of maturation, with the notable
exception of CD38/rgHPIV3.
The basis for the reduced expression of CD38 in response to
rgHPIV3 remains unknown. CD38 is an ectoenzyme involved in
inducing calcium signaling, and also is a receptor that mediatesintracellular signaling following binding to its counter-receptor
CD31. Signaling induced by CD38/CD31 interaction up-regulates
CD83 expression and IL-12 production and enhances DC-induced T
cell activation (Fedele et al., 2004; Frasca et al., 2006). CD38
clusters at the immunologic synapse between DC and T
lymphocytes (Munoz et al., 2008). The enzymatic and receptor
activities of CD38 also are important for DC recruitment to
inﬂamed tissue and subsequent migration to secondary lymphoid
tissue (Frasca et al., 2006; Partida-Sanchez et al., 2007). Thus,
reduced expression of CD38 has the potential for multiple effects
on HPIV3 immunobiology that remain to be investigated. To the
best of our knowledge, the only other instance of down-regulation
of CD38 surface expression on human DC was a recent report
involving the spirochete bacterium Borrelia garinii (Hartiala et al.,
2007). Inhibition of the expression of other maturation markers
has been noted previously with certain viruses. For example,
infection of DC with herpes simplex virus type 1 (Kruse et al.,
2000) or human cytomegalovirus (Senechal et al., 2004) results in
degradation of CD83.
In vivo, chemokines and cytokines expressed by maturing DC play
important roles in augmenting the inﬂammatory response in the
infected tissue as well as attracting and activating lymphocytes later in
the lymph node (Piqueras et al., 2006). Thus, impaired or altered
expression potentially could lead to reduced or inappropriately
polarized immune responses. Various previous reports have
described possible deﬁciencies in the response by individual viruses
among the trio tested here, including impaired production of
chemokines and cytokines by HMPV (Guerrero-Plata et al., 2006;
Tan et al., 2007), or a response to HRSV that is biased towards the
expression of immunosuppressive mediators such as IL-10 (Bartz et
al., 2002) or IFN types I and III (Chi et al., 2006), or IL-1ra (Salkind et
al., 1991), or that HPIV3 was notably deﬁcient in the induction of IL-
12 (Horga et al., 2005). In the present side-by-side comparison,
rgHRSV was notably deﬁcient in producing IFNα/β whereas a
response was noted for rgHMPVs, and rgHPIV3 induced the greatest
response of all. With regard to the other assayed factors, the
patterns of expression by the three viruses in this side-by-side
comparison were remarkably similar, although the responses tended
to be somewhat lower for rgHRSV and somewhat higher for
rgHPIV3.
Measles virus and vaccinia virus are examples of pathogens that
interfere with DC function by inducing apoptosis (Engelmayer et al.,
1999; Fugier-Vivier et al., 1997). There are reports of increased
apoptosis occurring following inoculation of IDC with HRSV (Bartz
et al., 2003) or HPIV3 (Plotnicky-Gilquin et al., 2001). However, in
the present study, inoculation with each of the viruses – or with
LPS – resulted in a decrease rather than an increase in apoptosis at
40 h compared to mock-treated cells. This decrease, rather than
increase, in apoptosis probably reﬂects anti-apoptotic effects of
maturation, possibly mediated through the induction of anti-
apoptotic proteins of the Bcl-2 family (Arimilli et al., 2006;
Lundqvist et al., 2002).
In conclusion, when compared side-by-side, rgHMPVs, rgHRSV,
and rgHPIV3 were poorly infectious for monocyte-derived human
IDC and induced a low-to-moderate level of maturation as
measured by the expression of cell surface markers and cytokines.
Extrapolating to clinical infection, the low level of infectivity for
DC and the low-to-moderate level of induced DC maturation
might provide for reduced antigen presentation and T cell
activation. This might result in sub-optimal immune responses,
which could impede resolution of infection and reduce protection
against re-infection. This effect would be the greatest for HRSV
since it was the least efﬁcient in inducing DC maturation, and
would be consistent with the greater role of HRSV in acute
disease and re-infection (Collins and Crowe, 2007; Glezen, 1990;
Lee et al., 2005).
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Virus stock preparation
The construction of recombinant GFP-expressing (rg) HMPV (strain
CAN97-83), rgHRSV (strain A2) and rgHPIV3 (strain JS) was described
previously (Biacchesi et al., 2004; Hallak et al., 2000; Zhang et al.,
2005). The further modiﬁcation of rgHMPV to create rgHMPVs, which
involved silently removing tracts of A or T residues that were sites of
spontaneous mutations during passage in vitro, was described
previously (Biacchesi et al., 2007). To prepare virus stocks, conﬂuent
225 cm2 ﬂasks of Vero cells were infected at the low multiplicity of
infection (MOI) of 0.1 PFU/cell with low-passage recombinant
rgHMPVs, rgHRSV or rgHPIV3 in OptiPro SFM medium (Invitrogen,
Carlsbad, CA) supplemented with 4 mM L-glutamine (Invitrogen).
These conditions were used to keep the abundance of defective
interfering particles low, and at comparable levels for all three viruses.
Every 2 days, 40 μl/ml of medium of trypsin (TrypLE Select, Invitrogen)
was added to the rgHMPVs-infected ﬂasks to allow for cleavage
activation of the fusion protein needed to obtain infectious particles.
After 6 to 8 days, the cells were scraped into the overlying medium.
The suspension was vortexed for 30 s to release cell associated viral
particles. Cells and debris were removed by centrifugation at 1000 ×g
for 10 min. The clariﬁed supernatants were combined and were
loaded onto 30%/60% w/v sucrose step gradients and subjected to
centrifugation in a Beckman SW28 rotor at 121,000 ×g for 90 min. The
virus-containing band was collected from the 30%/60% sucrose
interface, pooled and diluted 8-fold with Advanced RMPI 1640
(Invitrogen) supplemented with 2 mM L-glutamine. Viruses were
pelleted in 40 ml polycarbonate tubes in a Beckman JA-17 rotor at
8000 ×g for 2 h. This ﬁnal low speed spin removed sucrose without
reducing infectivity: initial studies indicated that the presence of
sucrose interfered with DC maturation (results not shown). After
centrifugation, supernatants were discarded and virus pellets were
resuspended in Advanced RMPI 1640 supplemented with 2 mM
L-glutamine and aliquots were snap frozen and stored at −80 °C until
use. Virus titers were determined by plaque assay on Vero cells under
methylcellulose overlay (containing trypsin for titration of rgHMPVs)
as described previously (Biacchesi et al., 2004). On day 5, plaques were
visualized on a Typhoon 8600 scanner (GE Healthcare, Piscataway, NJ).
In all experiments, UV-inactivated viruses were included as controls
and were prepared using a Stratalinker UV cross-linker (Agilent, Santa
Clara, CA) at 0.5 J/cm2, with inactivation monitored by plaque assay.
Generation of monocyte-derived IDC
Elutriated monocytes obtained from healthy adult donors at the
National Institutes of Health Clinical Center Blood Bank (clinical
protocol number 99-CC-0168) were subjected to CD14+ positive
sorting on an Automacs separator (Miltenyi Biotec, Auburn, CA)
using magnetic microbeads coated with a CD14 speciﬁc monoclonal
antibody (Miltenyi Biotec). The purity of the monocyte preparation
was conﬁrmed by ﬂow cytometry to be N98%. The CD14+ monocytes
were seeded in 12-well plates at 6×105 cells per well in Advanced
RMPI 1640 (Invitrogen) supplemented with 10% heat-inactivated FBS
(Hyclone, Logan, UT), 2 mM L-glutamine (Invitrogen), 200 U/ml
penicillin, 200 μg/ml streptomycin (Invitrogen), 0.05 mM 2-mercap-
toethanol (Sigma, St. Louis, MO), 16 ng/ml recombinant human IL-4
(R&D Systems, Minneapolis, MN) and 50 ng/ml recombinant human
granulocyte-macrophage colony-stimulating factor (GM-CSF; Leu-
kine®, Bayer Healthcare, Wayne, NJ) at 37 °C in 5% CO2. On day 7,
the immature DC were carefully harvested, washed and resuspended
in Advanced RMPI 1640 supplemented with 2 mM L-glutamine before
infection. The cell surface marker proﬁles were evaluated by ﬂow
cytometry, and found to be typical for IDC (CD1a+, CD14 low, CD38
low, CD11c high).Inoculation or stimulation of DC
IDC were seeded in 12-well plates at 6×105 cells per well and were
mock infected or infected with live virus at an input MOI of 3 PFU/cell
or with an equivalent amount of UV-inactivated virus. Parallel cells
were incubated with 1 μg/ml of lipopolysaccharide (LPS) from
Escherichia Coli O55:B5 (Sigma) as a positive control for cell
maturation. All experiments were performed in Advanced RMPI
1640 supplementedwith 10% heat-inactivated FBS, 2 mM L-glutamine,
200 U/ml penicillin and 200 μg/ml streptomycin at 37 °C in 5% CO2.
Flow cytometry analysis
The percentage of GFP-positive cells and the level of surface
expression of maturation markers were assessed by ﬂow cytometry.
Forty hours after inoculation, the DC were carefully harvested and
pelleted by centrifugation at 300 ×g for 10 min. After centrifugation,
DC were resuspended in cold washing solution (PBS [Invitrogen]
supplemented with 2% heat-inactivated FBS and 2 mM EDTA [Quality
Biological, Inc., Gaithersburg, MD]). To determine the level of
expression of the maturation markers, cells were stained with
phycoerythrin (PE)- or allophycocyanin (APC)-conjugated anti-
human mAbs from the following panel: PE-conjugated anti-CD1a
(HI149), anti-CD11c (S-HCL-3), anti-CD14 (M5E2), anti-CD54 (HA58),
anti-CD80 (L307.4) (all from BD Biosciences, San Jose, CA), and anti-
HLA-ABC (W6/32) (AbD Serotec, Raleigh, NC); and APC-conjugated
anti-CD38 (HIT2), anti-CD40 (5C3), anti-CD83 (HB15e), anti-CD86
(2331-FUN-1) (all from BD Biosciences). Isotype-matched mAbs as
negative controls were included in all experiments. The cells were
incubated with antibodies on ice for 20 min in the dark. After
incubation, cells were washed 3 times with cold washing solution and
resuspended in 200 μl of cold washing solution. Before ﬂow cytometry
analysis,10 μl of propidium iodide (PI) solution (200 μg/ml, Sigma)was
added to discriminate between live (PI negative) and dead (PI positive)
cells. Compensation was performed manually using hardware
compensation with single color control samples for GFP, PE and APC.
Spectral overlap of PE into the FL3, the PI detector for dead cell
exclusion, was also corrected using hardware compensation. Data was
acquired using a FACSCalibur ﬂow cytometer (BD Biosciences) on
20,000 events, excluding cell debris and dead cells. Forward scatter,
side scatter, live/dead staining, GFP expression, and cell surface
marker expression were analyzed using FlowJo version 8.5.2 software
(©Tree Star, Inc., Ashland, OR). Maturation marker expression was
analyzed individually (CD38, CD83, CD40, CD54) or in combination
(CD80, CD86). The use of multiple staining tubes per sample allowed
to control for absence of sample-to-sample variation of GFP
expression.
Measurement of cytokine production by matured DC
Culture supernatants were collected from duplicate wells of DC at
various time points (3, 14, 22 and/or 40 h) post treatment or
infection and clariﬁed by centrifugation at 300 ×g for 10 min.
Clariﬁed supernatants were stored at −80 °C in the presence of a
protease inhibitor cocktail (Roche Applied Science, Indianapolis, MN)
until analysis. ELISA kits were used to assess the concentration of
IFN-α (Human Interferon alpha multi subtype ELISA Kit, PBL
Biomedical Laboratories, Piscataway, NJ), IFN-β (Invitrogen), and
CXCL10 (IP10) (R&D Systems) according to the manufacturer's
instructions. All other cytokines (IL-1β, IL-2, IL-1ra, IL-4, IL-5, EGF,
IL-6, IL-7, TGFα, CX3CL1 (Fractalkine) CXCL8 (IL8), IL-10, IL-12(p70),
IL-13, IL-15, IL-17, IL-1α, IFN-γ, G-CSF, GM-CSF, TNFα, CCL11
(Eotaxin), CCL2 (MCP1), CCL3 (MIP1α), CCL4 (MIP1β), CCL5 (RANTES)
and VGEF were detected with a Luminex multiplex bead assay (Linco
Research, St. Charles, MO) according to the manufacturer's
instructions.
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Cell-associated RNAwas isolated using the RNeasy mini kit (Qiagen,
Valencia, CA) as recommended by the manufacturer and treated with
DNAse to remove residual genomic DNA. One to 200 ng of isolated RNA
was reverse transcribed using SuperScript II (Invitrogen) in a 25 μl mix
using random primers. 2 μl of the cDNA mix were used in each
quantitative TaqMan PCR (Applied Biosystems, Foster City, CA) for
quantiﬁcation of the targets of interest, namely CD38 or virus-expressed
GFP; β-actin or 18S rRNAwere used for normalization. The three viruses
contained different versions of the GFP gene and were ampliﬁed with
different primer sets: for rgHMPVs, the forward primer was 5′-
GAGCGCACCATCTTCTTCAAG-3′, the TaqMan probe was 5′-ACGACGG-
CAACTACA-3′, and the reverse primerwas 5′-TGTCGCCCTCGAACTTCAC-
3′; for rgHRSV, the forward primer was 5′-AGACCATATGAAGCAGCAT-
GACTTTT-3′, the TaqMan probe was 5′-TCCTGCACATAGCCC-3′ and the
reverse primer was 5′-GTCTTGTAGTTCCCGTCATCTTTGA-3′; and for
rgHPIV3, the forward primer was 5′-GCGGGATTTGTATACGAAA-
GAACGT-3′, the TaqMan probe was 5′-CCAGTCCACCATCTTC-3′, and the
reverse primerwas 5′-CTCTGTAGACAAACATCTCCTCGATTAAAT-3′. qPCR
results were analyzed using the comparative threshold cycle (ΔΔCT)
method, normalized to β-actin or 18S rRNA. Mock infected cells or cells
inoculated with UV-inactivated virus were used as calibrator. Results
were expressed as a fold-difference relative to uninfected cells (in the
case of CD38) or relative to cells inoculatedwith UV-inactivated virus (in
the case of GFP).
Apoptosis assays
IDC that were mock-inoculated or inoculated with the three
viruses as described above were evaluated for apoptosis 40 h post-
inoculation by ﬂow cytometry using (i) APC-labeled annexin-V
(Invitrogen) to detect cell membrane phospholipid phosphatidylser-
ine or (ii) a PE-labeled antibody to detect the activated form of
caspase-3 (BD Biosciences). Dead cells and cell debris were excluded
from analysis. As a positive control, additional cells were treated for
4 h with 5 μM staurosporine, a known inducer of apoptosis.
Statistical analysis
Data sets were assessed for signiﬁcance using parametric one-way
repeated measures ANOVAwith the Tukey post hoc tests for normally
distributed data sets or the non-parametric Friedman test with Dunns
post hoc test for non-normal data sets. A log10 transformation was
applied to data sets when necessary to obtain equal standard
deviations among groups, a necessary requirement of both tests. A
ﬁnal Bonferroni correction was applied to the whole family of the
ANOVA/Tukey and Friedman/Dunns tests for each “global” experiment
to maintain a total signiﬁcance level of 0.05. These “global”
experiments were (i) the analysis of the maturation marker expres-
sion of the global populations of DC (Fig. 2; 10 different donors, 8
different treatments and 7maturationmarkers), (ii) the analysis of the
maturation marker expression of the GFP-positive versus GFP-
negative cells (Fig. 3; 10 different donors, 7 different treatments, 7
different markers), and (iii) the analysis of the cytokine concentrations
at 40 h in the supernatant of mock- or virus-inoculated DC (Fig. 5; 6
different donors at the 40 h.p.i. time point, 5 different treatments, 8
different cytokines). Statistics were performed on the Prism 5 version
(© 1992–2008 GraphPad Software, Inc., San Diego, CA). Datawere only
considered signiﬁcant at (family-wise error rate) Pb0.05.
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